Biomarkers Found That Predict Lung Cancer Patient Response To Therapy
January 31st, 2008
Researchers at UCLA’s Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.

